Evidence map›Paper›PMID 31798477›Full record

ArticleFrontiers in psychiatry2019

The Prevalence of Hepatitis E in a Patient Cohort Presenting With Addictive Injection Behavior.

Antoine Yrondi, Juliette Salles, Jean Marie Péron, Marie Sporer, Simon Taib, Adeline Gallini, Chloé Noilhan, Chloé Dimeglio, Flora Entajan, Marie Crequy and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in psychiatry, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Antoine YrondiService de Psychiatrie et de Psychologie Médicale, Centre Expert Dépression Résistante FondaMental, CHU Toulouse, Hospital Purpan, ToNIC, Toulouse NeuroImaging Center, Université de Toulouse, Inserm, UPS, Toulouse, France.
Juliette SallesService de Psychiatrie et de Psychologie Médicale, CHU de Toulouse, Hospital Purpan, Toulouse, France.
Jean Marie PéronService d'Hépatologie, Hôpital Rangueil Centre Hospitalier Universitaire de Toulouse, Université Paul Sabatier Toulouse III, Toulouse, France.
Marie SporerService de Psychiatrie et de Psychologie Médicale, CHU de Toulouse, Hospital Purpan, Toulouse, France.
Simon TaibService de Psychiatrie et de Psychologie Médicale, CHU Toulouse, Hospital Purpan, ToNIC, Toulouse NeuroImaging Center, Université de Toulouse, Inserm, UPS, Toulouse, France.
Adeline GalliniUMR1027, INSERM University of Toulouse, Toulouse, France.
Chloé NoilhanDepartment of Epidemiology and Public Health, Centre Hospitalier Universitaire Toulouse (University Hospital Centre), Toulouse, France.
Chloé DimeglioINSERM U1043-CNRS UMR5282-Toulouse University Paul Sabatier, CPTP, Toulouse, France.
Flora EntajanCSAPA Maurice Dide, CHU Toulouse, Toulouse, France.
Marie CrequyCSAPA Maurice Dide, CHU Toulouse, Toulouse, France.
Jacques IzopetINSERM U1043-CNRS UMR5282-Toulouse University Paul Sabatier, CPTP, Toulouse, France.
Laurent SchmittService de Psychiatrie et de Psychologie Médicale, CHU de Toulouse, Hospital Purpan, Toulouse, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

addictionhepatitis Einjectionintravenousseroprevalence

Identifiers

PMID31798477
PMCPMC6874121

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.